Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €8.50 EUR
Change Today +2.37 / 38.58%
Volume 3.7K
APS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 3:38 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - ariad pharmaceuticals inc (APS)

Name (Connections)Board RelationshipsTitleKey Developments
Wayne Wilson 32 RelationshipsLead Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeAriad Pharmaceuticals Inc. announced delayed 10-Q filing
08/17/99
Jay LaMarche 9 RelationshipsIndependent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 
Massimo Radaelli Ph.D. 51 RelationshipsIndependent Director, Member of Audit Committee and Member of Science & Medicine Committee 

Compensation Committee* - ariad pharmaceuticals inc (APS)

Name (Connections)Board RelationshipsTitle
Athanase Lavidas Ph.D. 16 RelationshipsIndependent Director, Chairman of Nominating and Corporate Governance Committee and Member of Compensation Committee
Norbert Riedel Ph.D. 174 RelationshipsDirector, Chairman of Compensation Committee and Member of Science & Medicine Committee
APS Compensation vs. Industry
751.0K
354.4K
Chief Executive Officer
466.0K
262.5K
Chief Financial Officer
Share price activity for ARIAD PHARMACEUTICALS INC (APS)
52 Week Price Performance
APS
Industry Average

Nominating Committee* - ariad pharmaceuticals inc (APS)

Name (Connections)Board RelationshipsTitleKey Developments
Athanase Lavidas Ph.D. 16 RelationshipsIndependent Director, Chairman of Nominating and Corporate Governance Committee and Member of Compensation CommitteeAriad Pharmaceuticals Inc. Announces Management Changes
04/29/15
Wayne Wilson 32 RelationshipsLead Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeARIAD Pharmaceuticals Appoints Thomas J. Desrosier as Executive Vice President, Chief Legal and Administration Officer, and Secretary
01/22/15
Jay LaMarche 9 RelationshipsIndependent Director, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeAriad Pharmaceuticals Inc. Announces Resignation of Robert M. Whelan, Jr. as Director, Member of the Audit Committee and the Compensation Committee, Effective October 1, 2014
09/18/14
Alexander Denner Ph.D. 42 RelationshipsDirector and Member of Nominating & Corporate Governance CommitteeARIAD Pharmaceuticals, Inc. Announces Three Key Appointments to Global Management Team
06/23/14

Corporate Governance Committee* - ariad pharmaceuticals inc (APS)

Name (Connections)Board RelationshipsTitle
Alexander Denner Ph.D. 42 RelationshipsIndependent Director, Chairman of Nominating and Corporate Governance Committee and Member of Compensation Committee
Jay LaMarche 9 RelationshipsDirector, Chairman of Compensation Committee and Member of Science & Medicine Committee
Athanase Lavidas Ph.D. 16 Relationships--
Wayne Wilson 32 Relationships--
APS and Competitor
Insiders vs. External
Board
10%
90%
Ariad Pharmaceuticals Inc.
9%
91%
Array BioPharma Inc.
15%
85%
Exelixis, Inc.
0%
100%
Evotec AG
50%
50%
Pfizer Limited
29%
71%
INSYS Therapeutics, Inc.
Insiders
External Board Members

Executive Committee* - ariad pharmaceuticals inc (APS)

Name (Connections)Board RelationshipsTitle
Harvey Berger M.D. 9 RelationshipsPrincipal Founder, Chairman, Chief Executive Officer and President
Jay LaMarche 9 RelationshipsIndependent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Athanase Lavidas Ph.D. 16 RelationshipsIndependent Director, Chairman of Nominating and Corporate Governance Committee and Member of Compensation Committee
Wayne Wilson 32 RelationshipsLead Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Elizabeth Wyatt 19 RelationshipsFormer Director, Member of Audit Committee and Member of the Executive Committee
Management Effectiveness Relative to the Industry
Return on Equity
NM
Return on Assets
NM
Return on Total Capital
NM
TEV/Total Revenue(LTM)
NM

Advisory Committee* - ariad pharmaceuticals inc (APS)

Name (Board Relationships)/Title Board Affiliations
Morris Loeb 9 Relationships
Chairman of Medical Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APS:GR €8.50 EUR +2.37

APS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Array BioPharma Inc $5.94 USD +0.10
Evotec AG €3.77 EUR -0.029
Exelixis Inc $6.05 USD -0.04
Insys Therapeutics Inc $33.83 USD +0.58
Pfizer Ltd/India 2,309 INR +21.80
View Industry Companies
 

Industry Analysis

APS

Industry Average

Valuation APS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 10.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.